Navigation Links
Apricus Biosciences, Inc. (APRI) Transforms From Development Company to Income Generating!
Date:3/14/2012

160; Other key NexACT®–based products in Apricus Bio's commercialization pipeline include Femprox®, a treatment for female sexual arousal disorder ("FSAD"), MycoVa ® for nail fungus and PrevOnco™, a treatment for hepatocellular liver carcinoma.

As a key part of Apricus Bio's transition to a commercial, specialty pharma, Damaj cited the recent or pending acquisitions and agreements in oncology and oncology supportive care, including of Topotarget USA and PediaRx with their FDA approved drugs:    Totect® (dexrazoxane HCl), Granisol™ (granisetron), and Aquoral™.  In addition, Damaj cited the fact that Apricus Bio was chosen to ring the closing bell at the NASDAQ Stock Market on March 9 as validation of the company's growth. He said that his key focus in 2012 will be to build a higher regard for Apricus Bio among individual and institutional investors, analysts and pharmaceutical partners.

Among the potential future advantages Damaj will continue to cite for Apricus Bio this year include Vitaros® coming to market in Canada, the currently anticipated approval of Vitaros® in Europe, three products coming to market in the U.S., plus the company's strong cash position. For more on Apricus Bio, see: www.apricusbio.com.

The full interview is at: http://www.ceonews.tv/apri

About Apricus Biosciences, Inc.:

Apricus Bio is a San Diego-based, revenue-generating, specialty pharmaceutical company, with commercial products and a broad pipeline across numerous therapeutic classes.  Revenues and growth are driven from the sales of the Company's commercial products through its Apricus Pharmaceuticals USA, Inc. and NexMed (USA), Inc. subsidiaries and through out-licensing in certain territories of its product pipeline and NexACT(R) technology. Apricus Bio currently markets Tot
'/>"/>

SOURCE Apricus Biosciences, Inc.; CEONEWS.Tv
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
2. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
3. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
4. Ardea Biosciences, Inc. Announces New Clinical Development Program Directed Toward the Treatment of Gout
5. Novel PCT Method Unveiled by Pressure BioSciences, Inc. and Collaborators at the Harvard School of Public Health
6. Pressure BioSciences, Inc. Announces $850,000 NIH SBIR Phase II Award for the Development of a New PCT-dependent System for Improved Biomarker Discovery, Diagnostics, and Drug Discovery
7. Hollis-Eden Announces Name Change to Harbor BioSciences, Inc. and Ticker Symbol Change to HRBR
8. Neurocrine Biosciences, Inc. Prices Common Stock Offering
9. Regado Biosciences, Inc. Introduces REG2, Its Second Product Candidate, at the American College of Cardiology Conference, 59th Annual Scientific Session, in Atlanta, Georgia on March 15, 2010
10. Ampio Pharmaceuticals to Acquire DMI Biosciences, Inc.
11. Signum Biosciences, Inc. Announces Commercial Launch of Arazine™
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... , Aug. 31, 2015  Qualcomm Incorporated ... subsidiary, Qualcomm Life, Inc., is collaborating ... chronic care management solutions powered by Qualcomm Life,s ... Platform to enable continuous care, informed interventions and ... announced at Qualcomm Life,s annual Connect 2015 ...
(Date:8/31/2015)... 31, 2015  AMRI (NASDAQ: AMRI ) ... collaboration focused on the development, manufacture and marketing ... ("APIs"). The collaboration combines Saneca,s strength in extracting ... developing and manufacturing controlled substance APIs with AMRI,s ... processes into these facilities. The collaboration will also ...
(Date:8/31/2015)... August 31, 2015 Premune ... into an exclusive licensing agreement for Redonyl ® ... $300 million USD veterinary dermatology market, is a nutritional ... support healthy skin in dogs and cats. Redonyl ® ... , and has been received positively in the ...
Breaking Medicine Technology:Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 2Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 3Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 4Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 5AMRI Announces Agreement with Saneca Pharmaceuticals, a.s. for Portfolio of Opium-Derived Active Pharmaceutical Ingredients 2AMRI Announces Agreement with Saneca Pharmaceuticals, a.s. for Portfolio of Opium-Derived Active Pharmaceutical Ingredients 3AMRI Announces Agreement with Saneca Pharmaceuticals, a.s. for Portfolio of Opium-Derived Active Pharmaceutical Ingredients 4Premune Broadens Portfolio With Novel Innovet Skin Health Product 2Premune Broadens Portfolio With Novel Innovet Skin Health Product 3Premune Broadens Portfolio With Novel Innovet Skin Health Product 4
... The Food and Drug Administration says 12 brand ... abuse, overdoses, addiction, and even deaths across the U.S. ... (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) Find ... Sign up for e-mail notices of new FDA Consumer ...
... HILL, N.C., April 19, 2011 The oncology market ... biopharmaceutical industry, but managing all the aspects of successfully ... global strategic marketing functions supporting the oncology therapeutic area ... to run a high-performing group. Best Practices, ...
Cached Medicine Technology:Oncology Global Strategic Marketing Study Offers Chance for Resource Benchmarks 2
(Date:8/31/2015)... Cokato, MN (PRWEB) , ... August 31, 2015 , ... ... and new product introductions: The Terrace Outdoor Sauna. After months of extensive engineering and ... attractive sauna model built to withstand the elements and is offered at a very ...
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... ... provider of the CME-certified annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for ... be held Nov. 4 – 6 in New York City. The annual legacy ...
(Date:8/31/2015)... ... ... The more hours young adults spend watching television each day, the greater ... a 15-year analysis by the University of Pittsburgh Graduate School of Public Health revealed. ... adulthood is an important time to intervene and promote less television viewing, according to ...
(Date:8/31/2015)... ... August 31, 2015 , ... ... develop skills and assess their competencies in managing challenging conversations, announced today that ... the Defense Centers of Excellence for Psychological Health and Traumatic Brain Injury ...
(Date:8/31/2015)... IL (PRWEB) , ... August 31, 2015 , ... ... Cancer Awareness Month 2015 in September by sharing the facts about the role ... on BRCA1 and BRCA2 genetic mutations because of Angelina Jolie Pitt’s decisions to ...
Breaking Medicine News(10 mins):Health News:Say “Hello” to the Brand New Finnleo Terrace Outdoor Saunas 2Health News:Physicians’ Education Resource® Seeks Abstracts for the Upcoming Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® 2Health News:Physicians’ Education Resource® Seeks Abstracts for the Upcoming Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® 3Health News:Physicians’ Education Resource® Seeks Abstracts for the Upcoming Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® 4Health News:Watching More TV as a Young Adult Predicts Obesity 2Health News:Watching More TV as a Young Adult Predicts Obesity 3Health News:Kognito’s Glenn Albright to Present at DCoE Summit 2Health News:Foundation for Women’s Cancer Alerts Women to the Facts About the Role of Heredity in Gynecologic Cancers 2Health News:Foundation for Women’s Cancer Alerts Women to the Facts About the Role of Heredity in Gynecologic Cancers 3Health News:Foundation for Women’s Cancer Alerts Women to the Facts About the Role of Heredity in Gynecologic Cancers 4
... Now Available for all U.S. Counties, ATLANTA, June ... the United States, an increase of more than 3 ... data estimates,released today by the Centers for Disease Control ... the U.S. population has diabetes., In addition to ...
... New Orleans, LA Eugene A. Woltering, MD, FACS, The ... Sections of Surgical Oncology & Endocrine Surgery at LSU Health ... for a one-step method to rapidly identify "sentinel nodes;" the ... primary cancer. Preliminary research indicates that the procedure which consists ...
... Interactive, Most Innovative, Health Promotion/Disease, & Injury ... ... Education Information, INDIANAPOLIS, June 24 WellPoint, Inc. ... Health Awards from the Health,Information Resource Center. NuestroBien.com ( ...
... Americans are experiencing,rising prices on many essentials, including ... one of the fastest-growing medical,expenses. From 1990 to ... to $200.7 billion, according to a recent report ... Giant is introducing a new way for families, ...
... people at risk from cardiovascular disease (CVD) is set to ... black and minority ethnic groups. , QRisk2, an equation ... developing CVD for the first time, simultaneously takes into account ... such as family history of heart disease or diabetes. ...
... Forum Enables Public To Join The Discussion, NEW ... Control, more than 133 million Americans suffer from diabetes,asthma ... these,patients account for more than 75% of the nation,s ... continues to age over the next few,decades, its medical ...
Cached Medicine News:Health News:Number of People With Diabetes Increases to 24 Million 2Health News:Number of People With Diabetes Increases to 24 Million 3Health News:LSUHSC inventor awarded patent for new procedure to detect cancer spread 2Health News:LSUHSC inventor awarded patent for new procedure to detect cancer spread 3Health News:WellPoint Web Sites Receive Six World Wide Web Health Awards 2Health News:New Giant Pharmacy Program Offers Relief for Your Family and Your Wallet 2Health News:New cardiovascular score developed to improve heart attack and stroke detection 2Health News:Healthcare Experts Discuss Current and Future Challenges of Chronic Care on NewTalk 2Health News:Healthcare Experts Discuss Current and Future Challenges of Chronic Care on NewTalk 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: